DMRADamora Therapeutics, Inc.

$29.13

Is it safe?

Can DMRA take a bad year?

The deepest fall in DMRA's price history on file is −99%; it is 15% below its high today.

−99%

Worst drawdown on file · −15% today

Annualised volatility
343%

Annualised volatility · three times the market's own swing

Details
Cash and short-term investments
$541M
EBITDA, trailing twelve months
−$271M
Operating profit, trailing twelve months
−$271M
Annualised volatilitytwo years of daily moves
343%
Worst drawdown on file
−99%
Below its 52-week high
15%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.